|
Monday, 2nd November 2026
Articles
― Wednesday, 26th November 2025
Patent Blind Spots in India’s Startup and MSME Landscape Abstract India’s innovation economy is undergoing rapid expansion, powered by a thriving startup ecosystem and an extensive micro, small, and medium enterprise (MSME) sector. Despite their pivotal contributions to GDP, exports, and employment, the participation of these entities in the patent system remains disproportionately low. This underutilization exposes innovations to risks of misappropriation and constrains the nation’s ability to monetize intellectual property effectively. Through policy analysis, sectoral mapping, and comparative international observations, this research identifies systemic weaknesses spanning capability gaps, structural constraints, and missed opportunity pathways. Key barriers include prohibitive costs, procedural complexities, limited awareness, and sector-specific exclusions. The paper proposes strategic reforms aimed at embedding IP capability within entrepreneurial ecosystems, reducing procedural friction, enabling effective enforcement, and creating viable monetization channels. Strengthening patent engagement emerges as a critical lever for enhancing India’s technology sovereignty, global competitiveness, and long-term innovation resilience.
― Monday, 24th November 2025
Sovereign Patent Funds and Private Investment Funds: Strategic Instruments for Innovation-Led Growth in Emerging Economies
― Wednesday, 8th October 2025
"Funding the Fight: How TPLF can Empower Patent Infringement Battles for Startups & Individual inventors” Is Third-Party Litigation Funding the key to leveling the playing field for Indian Startups?
― Wednesday, 1st October 2025
The IP of AI Chip Design and TPU Patent Settlement: Shaping the Future of Semiconductor Innovation
― Wednesday, 23rd July 2025
Electrical Vehicles & Battery Market - Technology, IP Strategy & Litigation Electric Vehicles (EVs) and hybrid electric vehicles
(HEVs) rely heavily on battery and charging systems for zero-emission
transport. A deep dive into the IP landscape of this industry
reveals unique IP filing and litigation strategies that are fostering market
growth and business advantage. NethravathiD of IPpro analyzes these trends, offering
key takeaways and learnings for industry players.
#ElectricVehicles #EVs #BatteryTech
#IntellectualProperty #IPStrategy #Patents #TradeSecrets #Litigation
#Innovation #SustainableMobility #Patentpools #SEP #StandardessentialPatents
LOAD MORE
|
|
Monday, 2nd November 2026
IP Speak
― Monday, 2nd November 2026
Understanding the Importance of the Token Use Limitation on U.S. Trademark Rights with Help From a Litigious Beaver and Monty... READ MORE
― Monday, 2nd November 2026
Explained: Why India’s rejection of a TB drug patent matters for patients READ MORE
― Monday, 2nd November 2026
Indian scientist secures patent for in-vivo power generator after Bombay High Court order against IIT READ MORE
― Friday, 30th October 2026
Your Product Works: Do You Have the Rights to Commercialize It? READ MORE
LOAD MORE
|
|
Monday, 2nd November 2026
Current News
― Monday, 2nd November 2026
First Solar, CubicPV Enter into US Patent Licensing Agreement First Solar, Inc. (Nasdaq: FSLR) ("First Solar" or "the Company") has signed a non-exclusive patent licensing agreement with CubicPV Inc.
READ MORE
― Monday, 2nd November 2026
IIT-Kanpur patents bamboo-filled barriers to curb ground vibrations IIT-Kanpur patents bamboo-filled underground barriers to reduce ground vibrations, offering eco-friendly, cost-effective vibration control...
READ MORE
― Monday, 2nd November 2026
Microsoft Patents an AI That Can Literally Put Words in People’s Mouths in Real Time Microsoft just filed a patent for an AI product that would be able to transform live video in real time to alter speakers' words and faces...
READ MORE
― Friday, 30th October 2026
Indian Patent Office Refuses Patent for Tuberculosis Drug Combination The Indian Patent Office has rejected a patent application filed by the U.S. based Global Alliance for TB Drug Development (TB Alliance) for BPaL, a drug combination used to treat drug-resistant tuberculosis (TB).
READ MORE
― Friday, 30th October 2026
Bristol Myers Squibb Raises Full-Year Revenue Guidance as New Drugs Offset Patent Expiry Pressure on Older Drugs The growth portfolio added approximately $830 million in sales compared with a year ago, roughly equivalent to the company’s overall increment. The announcement attributed growth to Opdivo Qvantig, Breyanzi, and three other drugs, meaning growth does not depend on a single product launch. For a company replacing aging blockbuster drugs, this breadth is exactly what is needed. The legacy drug portfolio grew only 1%, and only because Eliquis outperformed generic erosion. Eliquis itself will face patent expiry later this decade, so this stability is temporary.
READ MORE
LOAD MORE
|
|
Monday, 2nd November 2026
Patent Office Update
― Friday, 30th October 2026
WHO, WIPO, and the WTO to hold 13th Joint Technical Symposium READ MORE
― Thursday, 29th October 2026
AI-powered solution for more accessible legal information across Europe READ MORE
― Wednesday, 28th October 2026
USPTO 101: The Risks of Subject Matter Eligibility Declarations READ MORE
― Tuesday, 27th October 2026
Trilateral offices meet in Vienna to advance Global Assignment and co-operation on AI READ MORE
LOAD MORE
|
| Site map | Follow us | Offices | ||||||||||||||||||
|
|
Bangalore | Silicon Valley | |||||||||||||||||
| Who are we | 102, Prestige Loka, 7/1, Brunton Road, Bangalore- 560 025, INDIA. |
220 California Ave, Suite 201, Palo Alto, CA- 94306, USA. |
||||||||||||||||||
| What we do | ||||||||||||||||||||
| Industry Expertise | ||||||||||||||||||||
| +91 80 6693 5000 | +1 650 325 7100 | |||||||||||||||||||
| Services | ||||||||||||||||||||
| Patent Drafting & Filing | Patent Prosecution | Patent Analytics & IP Strategy | IP Awareness Initiatives | Get in touch |
Mumbai | Singapore | ||||||||||||||
| Prior Art Search | Patent Prosecution | Patent Invalidation Search | Workshops & Seminars | |||||||||||||||||
| Patent Drafting Services | Patent Litigation Support | Freedom-To-Operate Analysis | Daily bulletin | ENQUIRE |
93-B Mittal Court, Nariman Point, Mumbai- 400 021, INDIA. |
Level 30, Six Battery Road, Singapore- 049909. |
||||||||||||||
| Patent Filing Services | Landscape Analysis | Research Articles | ||||||||||||||||||
| State of the art Search | ||||||||||||||||||||
| IP Watch | ||||||||||||||||||||
| IP Due Diligence | +91 22 6669 5000 | +65 6550 9855 | ||||||||||||||||||
| Copyrights © 2016 IPpro Services (India) LLP. All rights reserved. | ||||||||||||||||||||
